Neural cell differentiation method from ES cells

Details for Australian Patent Application No. 2005238202 (hide)

Owner Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute for Biomedical Research

Inventors Richter, Jens; Bibel, Miriam; Tucker, Kerry Lee; Barde, Yves-Alain

Agent Davies Collison Cave

Pub. Number AU-B-2005238202

PCT Pub. Number WO2005/105986

Priority 0410011.1 05.05.04 GB

Filing date 4 May 2005

Wipo publication date 10 November 2005

Acceptance publication date 9 October 2008

International Classifications

C12N 5/08 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/105986 Priority application(s): WO2005/105986

9 October 2008 Application Accepted

  Published as AU-B-2005238202

5 February 2009 Standard Patent Sealed

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005238203-Preparation of SCFV antibody fragments

2005238199-CRTh2 receptor antagonists